H3B-6545 in women with locally advanced/metastatic estrogen receptor-positive (ER+), HER2 negative (-) breast cancer (BC)

被引：0

作者：

Hamilton, Erika P.

Pluard, Timothy J.

Wang, Judy S.

Morikawa, Aki

Johnston, Stephen R. D.

Dees, Elizabeth Claire

Vaklavas, Christos

Armstrong, Anne C.

Munster, Pamela N.

Unni, Nisha

Wright, Gail Lynn Shaw

Kayali, Fadi

Song, Tingting

Rong, Yuanxin

Yamaguchi, Kohei

Juric, Dejan

机构：

[1] Sarah Cannon Res Inst, Nashville, TN USA

[2] St Lukes Canc Inst, Kansas City, MO USA

[3] Florida Canc Specialists Sarah Cannon Res Inst, Sarasota, FL USA

[4] Univ Michigan, Ann Arbor, MI USA

[5] Royal Marsden NHS Fdn Trust, London, England

[6] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA

[7] Univ Utah, Salt Lake City, UT USA

[8] Christie NHS Fdn Trust, Manchester, Lancs, England

[9] Univ Calif San Francisco, San Francisco, CA USA

[10] UT Southwestern Med Ctr, Dallas, TX USA

[11] Florida Canc Specialists Sarah Cannon Res Inst, Trinity, FL USA

[12] Florida Canc Specialists, Sarasota, FL USA

[13] Eisai Inc, Nutley, NJ USA

[14] Eisai & Co Ltd, Tokyo, Japan

[15] Harvard Med Sch, Boston, MA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1015

引用

页数：1